These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6201307)

  • 21. Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.
    Abrams PG; Ochs JJ; Giardina SL; Morgan AC; Wilburn SB; Wilt AR; Oldham RK; Foon KA
    J Immunol; 1984 Apr; 132(4):1611-3. PubMed ID: 6699400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FPLC purification of mouse monoclonal antibodies from ascitic fluid using blue DEAE and thiophilic sorbents.
    Juronen E; Parik J; Toomik P
    J Immunol Methods; 1991 Jan; 136(1):103-9. PubMed ID: 1995702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal antibodies to the Japanese encephalitis virus in ascitic hybridoma preparations].
    Deriabin PG; Loginova NV; Lebedeva GA; Novokhatskiĭ AS; Malakhova IV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):24-8. PubMed ID: 3947048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Passage of hybridomas in male BALB/c mice].
    Novikov VV; Trofimova MN; Zhil'tsova MA; Biriukova LZ
    Antibiot Khimioter; 1988 Nov; 33(11):836-8. PubMed ID: 3228324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaseline-peptone mixture as a stimulant of ascites formation in mouse hybridoma carriers].
    Baryshnikov AIu; Trofimova MN; Novikov VV; Polianskaia GA; Sandova OM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):90-3. PubMed ID: 3291501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.
    Britt WJ; Chesebro B
    J Immunol; 1983 May; 130(5):2363-7. PubMed ID: 6833759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clarification of ascites fluid.
    Baum G; Frey M; Santa Teresa J
    Biotechniques; 1991 Apr; 10(4):456, 458, 460. PubMed ID: 1651092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.
    Butchaiah G; Rao BU
    Acta Virol; 1989 Mar; 33(2):121-30. PubMed ID: 2569807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ascites production for monoclonal antibodies in BALB/c and BALB/c-derived cross-bred mice.
    Stewart F; Callander A; Garwes DJ
    J Immunol Methods; 1989 May; 119(2):269-75. PubMed ID: 2542413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparison of viral antibody titers of acid-precipitated and non-precipitated mouse ascitic fluids.
    Gamble WC; Chappell WA; George EH
    Health Lab Sci; 1978 Apr; 15(2):91-4. PubMed ID: 681182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The possibility of using outbred mice for the production of monoclonal antibodies].
    Novikov VV; Trofimova MN; Dubinkin IV; Komarova OB; Biriukova LZ
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):81-4. PubMed ID: 2816186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of the monoclonal antibodies induced by the Crimean hemorrhagic fever virus].
    Gaĭdamovich SIa; Mel'nikova EE; Shutkova TM; Novokhatskiĭ AS; Turchinskaia AL
    Vopr Virusol; 1989; 34(2):201-4. PubMed ID: 2503939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High yield monoclonal antibody production in ascites.
    Brodeur BR; Tsang PS
    J Immunol Methods; 1986 Feb; 86(2):239-41. PubMed ID: 3944476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and further characterization of an anti-murine interferon-gamma monoclonal neutralizing antibody.
    Havell EA
    J Interferon Res; 1986 Oct; 6(5):489-97. PubMed ID: 3100664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes.
    Reik LM; Maines SL; Ryan DE; Levin W; Bandiera S; Thomas PE
    J Immunol Methods; 1987 Jun; 100(1-2):123-30. PubMed ID: 3598193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.